Halozyme Therapeutics
HALO
#2005
Rank
โ‚น668.04 B
Marketcap
โ‚น5,274
Share price
0.90%
Change (1 day)
61.83%
Change (1 year)

EPS for Halozyme Therapeutics (HALO)

EPS in 2023 (TTM): โ‚น142.81

According to Halozyme Therapeutics's latest financial reports the company's current EPS (TTM) is โ‚น145.98. In 2022 the company made an earnings per share (EPS) of โ‚น124.16 a decrease over its 2021 EPS that were of โ‚น239.10.

EPS history for Halozyme Therapeutics from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น142.8115.02%
2022โ‚น124.16-48.07%
2021โ‚น239.10196.88%
2020โ‚น80.54-292%
2019-โ‚น41.95-9.09%
2018-โ‚น46.14-237.5%
2017โ‚น33.56-149.38%
2016-โ‚น67.95211.54%
2015-โ‚น21.81-52.73%
2014-โ‚น46.14-24.66%
2013-โ‚น61.2448.98%
2012-โ‚น41.11145%
2011-โ‚น16.78-64.29%
2010-โ‚น46.98-17.65%
2009-โ‚น57.059.68%
2008-โ‚น52.0193.75%
2007-โ‚น26.8533.33%
2006-โ‚น20.13-4%
2005-โ‚น20.97-3.85%
2004-โ‚น21.81-13.33%
2003-โ‚น25.1783.59%
2002-โ‚น13.71

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-โ‚น15.94-110.92%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น455.48 212.03%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น429.54 194.25%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น156.04 6.90%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น266.80 82.77%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น1,182 709.50%๐Ÿ‡บ๐Ÿ‡ธ USA